Annual Cash & Cash Equivalents
$4.09 M
-$1.30 M-24.17%
December 31, 2023
Summary
- As of February 26, 2025, RLMD annual cash & cash equivalents is $4.09 million, with the most recent change of -$1.30 million (-24.17%) on December 31, 2023.
- During the last 3 years, RLMD annual cash & cash equivalents has risen by +$1.60 million (+63.97%).
- RLMD annual cash & cash equivalents is now -90.79% below its all-time high of $44.44 million, reached on December 31, 2021.
Performance
RLMD Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$1.48 M
-$602.50 K-28.88%
September 30, 2024
Summary
- As of February 26, 2025, RLMD quarterly cash and cash equivalents is $1.48 million, with the most recent change of -$602.50 thousand (-28.88%) on September 30, 2024.
- Over the past year, RLMD quarterly cash and cash equivalents has increased by +$148.80 thousand (+11.15%).
- RLMD quarterly cash and cash equivalents is now -96.70% below its all-time high of $44.93 million, reached on March 31, 2022.
Performance
RLMD Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
RLMD Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -24.2% | +11.2% |
| 3 y3 years | +64.0% | -87.0% |
| 5 y5 years | -55.6% | -81.1% |
RLMD Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -90.8% | at low | -96.7% | +11.2% |
| 5 y | 5-year | -90.8% | +64.0% | -96.7% | +11.2% |
| alltime | all time | -90.8% | >+9999.0% | -96.7% | >+9999.0% |
Relmada Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.48 M(-28.9%) |
| Jun 2024 | - | $2.09 M(+56.3%) |
| Mar 2024 | - | $1.33 M(-67.4%) |
| Dec 2023 | $4.09 M(-24.2%) | $4.09 M(-38.9%) |
| Sep 2023 | - | $6.70 M(-53.7%) |
| Jun 2023 | - | $14.47 M(-49.9%) |
| Mar 2023 | - | $28.89 M(+435.5%) |
| Dec 2022 | $5.40 M(-87.9%) | $5.40 M(-87.3%) |
| Sep 2022 | - | $42.52 M(+14.1%) |
| Jun 2022 | - | $37.26 M(-17.1%) |
| Mar 2022 | - | $44.93 M(+1.1%) |
| Dec 2021 | $44.44 M(+1681.0%) | $44.44 M(+288.2%) |
| Sep 2021 | - | $11.45 M(+145.2%) |
| Jun 2021 | - | $4.67 M(+22.7%) |
| Mar 2021 | - | $3.80 M(+52.4%) |
| Dec 2020 | $2.50 M(-93.1%) | $2.50 M(-66.9%) |
| Sep 2020 | - | $7.54 M(-45.4%) |
| Jun 2020 | - | $13.82 M(+13.1%) |
| Mar 2020 | - | $12.23 M(+55.8%) |
| Dec 2019 | $36.28 M(+293.6%) | - |
| Sep 2019 | - | $7.85 M(-14.8%) |
| Jun 2019 | $9.22 M | $9.22 M(+348.7%) |
| Mar 2019 | - | $2.05 M(-15.4%) |
| Dec 2018 | - | $2.43 M(+173.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $887.50 K(-60.4%) |
| Jun 2018 | $2.24 M(+30.9%) | $2.24 M(-47.4%) |
| Mar 2018 | - | $4.26 M(-28.3%) |
| Dec 2017 | - | $5.94 M(+26.8%) |
| Sep 2017 | - | $4.68 M(+173.9%) |
| Jun 2017 | $1.71 M(-79.9%) | $1.71 M(-37.9%) |
| Mar 2017 | - | $2.76 M(-41.5%) |
| Dec 2016 | - | $4.71 M(-24.2%) |
| Sep 2016 | - | $6.22 M(-26.8%) |
| Jun 2016 | $8.50 M(-62.2%) | $8.50 M(-25.1%) |
| Mar 2016 | - | $11.35 M(-25.0%) |
| Dec 2015 | - | $15.13 M(-21.1%) |
| Sep 2015 | - | $19.17 M(-14.7%) |
| Jun 2015 | $22.47 M(-12.1%) | $22.47 M(-16.6%) |
| Mar 2015 | - | $26.96 M(-14.2%) |
| Dec 2014 | - | $31.42 M(+14.7%) |
| Sep 2014 | - | $27.39 M(>+9900.0%) |
| Jun 2014 | $25.56 M(>+9900.0%) | - |
| Feb 2014 | - | $2600.00(-58.1%) |
| Nov 2013 | - | $6200.00(-59.5%) |
| Aug 2013 | $15.30 K(+71.9%) | $15.30 K(+2085.7%) |
| May 2013 | - | $700.00(-90.7%) |
| Feb 2013 | - | $7500.00(-15.7%) |
| Aug 2012 | $8900.00 | $8900.00 |
FAQ
- What is Relmada Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Relmada Therapeutics?
- What is Relmada Therapeutics annual cash & cash equivalents year-on-year change?
- What is Relmada Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Relmada Therapeutics?
- What is Relmada Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Relmada Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of RLMD is $4.09 M
What is the all time high annual cash & cash equivalents for Relmada Therapeutics?
Relmada Therapeutics all-time high annual cash & cash equivalents is $44.44 M
What is Relmada Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, RLMD annual cash & cash equivalents has changed by -$1.30 M (-24.17%)
What is Relmada Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of RLMD is $1.48 M
What is the all time high quarterly cash and cash equivalents for Relmada Therapeutics?
Relmada Therapeutics all-time high quarterly cash and cash equivalents is $44.93 M
What is Relmada Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, RLMD quarterly cash and cash equivalents has changed by +$148.80 K (+11.15%)